Predictive Value of 99mTc- Albumin Spheres Before 90Y- SIR Therapy
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the predictive value of 99mTechnetium (Tc)- labeled
albumin in macroaggregates (MAA) and in microspheres (B20) injected into the common hepatic
artery for the distribution of 90Yttrium- Selective Internal Radiotherapy (SIRT)-spheres
(SIR- spheres).